Ambase CORP 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

OTC.Pink
AmBase Corporation announced an additional $1 million in litigation funding from CEO Richard A. Bianco, bringing the total to $7 million, to support working capital and ongoing legal expenses related to the 111 West 57th Property.
OTC.Pink
AmBase Corporation reports the successful re-election of director Richard A. Bianco and advisory approval of executive compensation at its 2026 annual meeting.
OTC.Pink
AmBase Corporation has secured $6 million in litigation funding from its CEO and converted $2 million in debt from BARC Investments to continue its 111 West 57th Property litigation, addressing its going concern qualification.
OTC.Pink
AmBase Corporation obtained a $300,000 loan from its Chairman and CEO, Richard A. Bianco, to support working capital and ongoing litigation efforts.
OTC.Pink
AmBase Corporation has entered into a $100,000 senior promissory note with its Chairman, President, and CEO, Richard A. Bianco, to secure working capital and support ongoing litigation.
OTC.Pink
AmBase Corporation reported that Joseph R. Bianco ceased employment with the company effective January 1, 2026.
OTC.Pink
AmBase Corporation secured a $300,000 loan from its Chairman and CEO, Richard A. Bianco, to support ongoing operations and litigation related to the 111 West 57th Property.
OTC.Pink
AmBase Corporation secured a $100,000 loan from its Chairman, President, and CEO, Richard A. Bianco, to support working capital and ongoing litigation efforts, while continuing to address a 'going concern' qualification.
OTC.Pink
AmBase Corporation has entered into a $250,000 senior promissory note with its CEO, Richard A. Bianco, to secure working capital and support ongoing litigation.
OTC.Pink
AmBase Corporation obtained a $100,000 loan from its CEO, Richard A. Bianco, to support working capital and ongoing litigation efforts, amidst a going concern qualification.
OTC.Pink
AmBase Corporation's Chairman, President, and CEO, Richard A. Bianco, provided a $250,000 loan to the company for working capital, highlighting ongoing financial challenges and the pursuit of litigation funding.
OTC.Pink
AmBase Corporation has entered into a $500,000 senior promissory note with its Chairman, President, and CEO, Richard A. Bianco, to provide essential working capital and support its ongoing litigation related to the 111 West 57th Property.
OTC.Pink
AmBase Corporation reported the results of its annual stockholders meeting held on June 6, 2025, confirming the election of two directors and the continuation of terms for two others.
OTC.Pink
AmBase Corporation has entered into a $100,000 senior promissory note with its Chairman and CEO, Richard A. Bianco, to provide working capital as the company continues to face going concern qualifications and seeks additional funding.
OTC.Pink
AmBase Corporation reports the resignation of Marcum LLP as its independent registered public accounting firm and the engagement of CBIZ CPAs as its new auditor, effective April 22, 2025.
OTC.Pink
AmBase Corporation entered into a Senior Promissory Note with its CEO, Richard A. Bianco, for a $400,000 loan to support working capital and ongoing litigation related to the 111 West 57th Property.
OTC.Pink
AmBase Corporation entered into a Senior Promissory Note with its CEO, Richard A. Bianco, for a $100,000 loan to support working capital and ongoing litigation related to the 111 West 57th Property.
OTC.Pink
AmBase Corporation has entered into a $500,000 loan agreement with its CEO, Richard A. Bianco, to provide working capital and support ongoing litigation related to the 111 West 57th Property.
OTC.Pink
AmBase Corporation has entered into a $1 million loan agreement with its CEO, Richard A. Bianco, to provide working capital while the company continues to pursue litigation related to the 111 West 57th property.
OTC.Pink
AmBase Corporation has entered into a $2 million loan agreement with BARC Investments, LLC, an affiliate, to provide working capital and support ongoing litigation related to the 111 West 57th Property.
OTC.Pink
Ambase Corporation held its annual stockholder meeting on June 2, 2024, where a director was elected, the appointment of an accounting firm was ratified, and an increase in authorized shares was approved.
OTC.Pink
AmBase Corporation reports the passing of board member Jerry Y. Carnegie, who had previously announced his intention to not seek re-election.
OTC.Pink
AmBase Corporation successfully concluded a private placement offering, issuing 44,200,460 shares of common stock at $0.20 per share, raising capital and involving a significant purchase by an affiliated entity.
OTC.Pink
AmBase Corporation has entered into a $100,000 loan agreement with its CEO, Richard A. Bianco, to provide working capital while it finalizes a private placement offering.
OTC.Pink
AmBase Corporation has initiated a private placement offering of common stock to existing shareholders to raise approximately $8.8 million to fund operations and litigation.
OTC.Pink
AmBase Corporation has entered into a $100,000 loan agreement with its CEO and plans a $8.8 million equity offering to fund operations and litigation.
OTC.Pink
AmBase Corporation will commence a private placement offering to existing shareholders to raise approximately $8.8 million to fund operations and litigation related to the 111 West 57th Property.
OTC.Pink
AmBase Corporation has entered into a $50,000 loan agreement with its CEO, Richard A. Bianco, to provide working capital while the company explores strategic funding options.
OTC.Pink
AmBase Corporation has entered into a $100,000 loan agreement with its CEO, Richard A. Bianco, to provide working capital while the company explores strategic funding options.